标题
JAK/STAT signaling in hematological malignancies
作者
关键词
-
出版物
ONCOGENE
Volume 32, Issue 21, Pages 2601-2613
出版商
Springer Nature
发表日期
2012-08-06
DOI
10.1038/onc.2012.347
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- INCB16562, a JAK1/2 Selective Inhibitor, Is Efficacious against Multiple Myeloma Cells and Reverses the Protective Effects of Cytokine and Stromal Cell Support
- (2015) Jun Li et al. NEOPLASIA
- Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in mice
- (2012) C. Walz et al. BLOOD
- Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group Study
- (2012) I.-M. Chen et al. BLOOD
- JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths
- (2012) A. Tefferi BLOOD
- Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia
- (2012) M. Porcu et al. BLOOD
- Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
- (2012) R. Beekman et al. BLOOD
- Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes
- (2012) C. Pecquet et al. BLOOD
- Janus kinase Inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?
- (2012) Claire Harrison et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
- (2012) Oliver Weigert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
- (2012) Jinghui Zhang et al. NATURE
- BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
- (2012) Oliver Hantschel et al. Nature Chemical Biology
- GermlineJAK2Mutation in a Family with Hereditary Thrombocytosis
- (2012) Adam J. Mead et al. NEW ENGLAND JOURNAL OF MEDICINE
- Challenges Facing JAK Inhibitor Therapy for Myeloproliferative Neoplasms
- (2012) Ayalew Tefferi NEW ENGLAND JOURNAL OF MEDICINE
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of everolimus, a mTOR inhibitor, as single agent in a phase 1/2 study in patients with myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- EZH2 mutational status predicts poor survival in myelofibrosis
- (2011) P. Guglielmelli et al. BLOOD
- Critical requirement for Stat5 in a mouse model of polycythemia vera
- (2011) D. Yan et al. BLOOD
- JAK2 rearrangements, including the novel SEC31A-JAK2 fusion, are recurrent in classical Hodgkin lymphoma
- (2011) K. Van Roosbroeck et al. BLOOD
- FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma
- (2011) N. E. Elliott et al. BLOOD
- Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
- (2011) F. Passamonti et al. BLOOD
- PTPN2 negatively regulates oncogenic JAK1 in T-cell acute lymphoblastic leukemia
- (2011) M. Kleppe et al. BLOOD
- High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia
- (2011) W. Warsch et al. BLOOD
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression
- (2011) T. Klampfl et al. BLOOD
- JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
- (2011) Fan Liu et al. CANCER CELL
- Structural Linkage between Ligand Discrimination and Receptor Activation by Type I Interferons
- (2011) Christoph Thomas et al. CELL
- Jak1 Has a Dominant Role over Jak3 in Signal Transduction through γc-Containing Cytokine Receptors
- (2011) Claude Haan et al. CHEMISTRY & BIOLOGY
- IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation
- (2011) Wei Liao et al. CURRENT OPINION IN IMMUNOLOGY
- Mutation analysis of the tyrosine phosphatase PTPN2 in Hodgkin's lymphoma and T-cell non-Hodgkin's lymphoma
- (2011) M. Kleppe et al. HAEMATOLOGICA
- Oncogenic JAK1 and JAK2-activating mutations resistant to ATP-competitive inhibitors
- (2011) T. Hornakova et al. HAEMATOLOGICA
- Protein Arginine Methyltransferase 5 (PRMT5) Signaling Suppresses Protein Kinase Cδ- and p38δ-dependent Signaling and Keratinocyte Differentiation
- (2011) Santosh R. Kanade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Janus-Activated Kinase 2 Inhibitors: A New Era of Targeted Therapies Providing Significant Clinical Benefit for Philadelphia Chromosome–Negative Myeloproliferative Neoplasms
- (2011) Srdan Verstovsek JOURNAL OF CLINICAL ONCOLOGY
- Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
- (2011) Animesh Pardanani et al. JOURNAL OF CLINICAL ONCOLOGY
- Gain-of-function mutations ininterleukin-7 receptor-α(IL7R) in childhood acute lymphoblastic leukemias
- (2011) Chen Shochat et al. JOURNAL OF EXPERIMENTAL MEDICINE
- GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activation
- (2011) Jean Charles Nault et al. JOURNAL OF HEPATOLOGY
- Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
- (2011) A Deshpande et al. LEUKEMIA
- Description of a novel Janus kinase 3 P132A mutation in acute megakaryoblastic leukemia and demonstration of previously reported Janus kinase 3 mutations in normal subjects
- (2011) Ludovica Riera et al. LEUKEMIA & LYMPHOMA
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia
- (2011) Priscila P Zenatti et al. NATURE GENETICS
- PRMT5 restricts ERK activity
- (2011) Katharine H. Wrighton NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The pseudokinase domain of JAK2 is a dual-specificity protein kinase that negatively regulates cytokine signaling
- (2011) Daniela Ungureanu et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- SomaticSF3B1Mutation in Myelodysplasia with Ring Sideroblasts
- (2011) E. Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
- (2010) Vijay Ramakrishnan et al. AMERICAN JOURNAL OF HEMATOLOGY
- Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies
- (2010) Ulrike Bacher et al. ANNALS OF HEMATOLOGY
- miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets
- (2010) M. Girardot et al. BLOOD
- G-CSF and its receptor in myeloid malignancy
- (2010) R. Beekman et al. BLOOD
- Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
- (2010) S. T. Oh et al. BLOOD
- Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells
- (2010) M. Lu et al. BLOOD
- Myeloproliferative neoplasm induced by constitutive expression of JAK2V617F in knock-in mice
- (2010) C. Marty et al. BLOOD
- New insights into the mechanisms of hematopoietic cell transformation by activated receptor tyrosine kinases
- (2010) F. Toffalini et al. BLOOD
- Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease
- (2010) H. Akada et al. BLOOD
- JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia
- (2010) J. Li et al. BLOOD
- Clinical utility of routineMPLexon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis
- (2010) Elaine M. Boyd et al. BRITISH JOURNAL OF HAEMATOLOGY
- Distinct Clinical Phenotypes Associated with JAK2V617F Reflect Differential STAT1 Signaling
- (2010) Edwin Chen et al. CANCER CELL
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
- (2010) Ann Mullally et al. CANCER CELL
- Cbl and Human Myeloid Neoplasms: The Cbl Oncogene Comes of Age: Figure 1.
- (2010) Stephen C. Kales et al. CANCER RESEARCH
- New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice
- (2010) C. G. Mullighan CLINICAL CANCER RESEARCH
- Absence of gain-of-function JAK1 and JAK3 mutations in adult T cell leukemia/lymphoma
- (2010) T. Kameda et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
- (2010) Sachie Marubayashi et al. JOURNAL OF CLINICAL INVESTIGATION
- Lnk constrains myeloproliferative diseases in mice
- (2010) Alexey Bersenev et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of JAK–STAT signaling by TG101348: a novel mechanism for inhibition of KITD816V-dependent growth in mast cell leukemia cells
- (2010) T Lasho et al. LEUKEMIA
- The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
- (2010) A Scuto et al. LEUKEMIA
- LNK mutation studies in blast-phase myeloproliferative neoplasms and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
- (2010) A Pardanani et al. LEUKEMIA
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors
- (2010) Alexandra Dusa et al. PLoS One
- Regulation of hematopoietic stem cells by their mature progeny
- (2010) C. A. de Graaf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Senescence-Like Cell-Cycle Arrest Occurs During Megakaryocytic Maturation: Implications for Physiological and Pathological Megakaryocytic Proliferation
- (2010) Rodolphe Besancenot et al. PLOS BIOLOGY
- Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
- (2009) L. Malcovati et al. BLOOD
- Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma
- (2009) O. Ritz et al. BLOOD
- Induction of myeloproliferative disorder and myelofibrosis by thrombopoietin receptor W515 mutants is mediated by cytosolic tyrosine 112 of the receptor
- (2009) C. Pecquet et al. BLOOD
- Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma
- (2009) A. Navarro et al. BLOOD
- Ubiquitination and degradation of the thrombopoietin receptor c-Mpl
- (2009) S. J. Saur et al. BLOOD
- Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
- (2009) L. Hertzberg et al. BLOOD
- Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
- (2009) L. J. Russell et al. BLOOD
- Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
- (2009) F. H. Grand et al. BLOOD
- SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases
- (2009) J. Elliott et al. HAEMATOLOGICA
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Methylation status of nine tumor suppressor genes in multiple myeloma
- (2009) Esteban Braggio et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Acute Lymphoblastic Leukemia-associated JAK1 Mutants Activate the Janus Kinase/STAT Pathway via Interleukin-9 Receptor α Homodimers
- (2009) Tekla Hornakova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- An activating mutation in theCSF3Rgene induces a hereditary chronic neutrophilia
- (2009) Isabelle Plo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- SOCS3 inhibits TPO-stimulated, but not spontaneous, megakaryocytic growth in primary myelofibrosis
- (2009) R Chaligné et al. LEUKEMIA
- MPLW515L mutation in acute megakaryoblastic leukaemia
- (2009) K Hussein et al. LEUKEMIA
- STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line
- (2009) D Baus et al. LEUKEMIA
- Mutations of ASXL1 gene in myeloproliferative neoplasms
- (2009) N Carbuccia et al. LEUKEMIA
- Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
- (2009) Chunaram Choudhary et al. MOLECULAR CELL
- SOCS1 Links Cytokine Signaling to p53 and Senescence
- (2009) Viviane Calabrese et al. MOLECULAR CELL
- JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin
- (2009) Mark A. Dawson et al. NATURE
- A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms
- (2009) Damla Olcaydu et al. NATURE GENETICS
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- Rearrangement of CRLF2 in B-progenitor– and Down syndrome–associated acute lymphoblastic leukemia
- (2009) Charles G Mullighan et al. NATURE GENETICS
- JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
- (2009) Amy V Jones et al. NATURE GENETICS
- Mutation inTET2in Myeloid Cancers
- (2009) François Delhommeau et al. NEW ENGLAND JOURNAL OF MEDICINE
- JAK mutations in high-risk childhood acute lymphoblastic leukemia
- (2009) C. G. Mullighan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes
- (2008) G. Wernig et al. BLOOD
- MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort
- (2008) P. A. Beer et al. BLOOD
- Activating mutations in human acute megakaryoblastic leukemia
- (2008) S. Malinge et al. BLOOD
- Specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukemia
- (2008) L. Kearney et al. BLOOD
- Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
- (2008) M. H. Tomasson et al. BLOOD
- YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation
- (2008) I. S. Hitchcock et al. BLOOD
- Prevalence and clinical correlates ofJAK2mutations in Down syndrome acute lymphoblastic leukaemia
- (2008) Amos Gaikwad et al. BRITISH JOURNAL OF HAEMATOLOGY
- A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia
- (2008) Gabriella Cirmena et al. CANCER GENETICS AND CYTOGENETICS
- Somatic Mutations of JAK1 and JAK3 in Acute Leukemias and Solid Cancers
- (2008) E. G. Jeong et al. CLINICAL CANCER RESEARCH
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
- (2008) L. Hennighausen et al. GENES & DEVELOPMENT
- NovelSSBP2-JAK2fusion gene resulting from a t(5;9)(q14.1;p24.1) in pre-B acute lymphocytic leukemia
- (2008) Jennifer L. Poitras et al. GENES CHROMOSOMES & CANCER
- Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases
- (2008) Luciana Teofili et al. INTERNATIONAL JOURNAL OF CANCER
- PIASy Represses CCAAT/Enhancer-binding Protein δ (C/EBPδ) Transcriptional Activity by Sequestering C/EBPδ to the Nuclear Periphery
- (2008) Shanggen Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Substitution of Pseudokinase Domain Residue Val-617 by Large Non-polar Amino Acids Causes Activation of JAK2
- (2008) Alexandra Dusa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Somatically acquiredJAK1mutations in adult acute lymphoblastic leukemia
- (2008) Elisabetta Flex et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mutation Profile of JAK2 Transcripts in Patients with Chronic Myeloproliferative Neoplasias
- (2008) Wanlong Ma et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition
- (2008) R Chaligné et al. LEUKEMIA
- Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia
- (2008) K Nebral et al. LEUKEMIA
- Src family kinases promote AML cell survival through activation of signal transducers and activators of transcription (STAT)
- (2008) Yukiyasu Ozawa et al. LEUKEMIA RESEARCH
- JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies
- (2008) William Vainchenker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
- (2007) Z. Xiang et al. BLOOD
- Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
- (2007) R. Tiedt et al. BLOOD
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started